CI
Strong BuyFull HouseAPPROVEThe Cigna Group · Healthcare · United States · $73.7B · Avg Vol: $399M/d
Full House: Strong business, sensible price, market agrees. The rare full house.
The Cigna Group generates substantial free cash flow from health services and pharmacy benefits, funds a large ongoing buyback and a rising dividend, and screens cheap on value (V77). Its exit from Medicare Advantage removed the segment causing the worst cost-trend volatility across the sector. The trivial insider selling is routine and nothing adverse is known on accounting or solvency.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT THE CIGNA GROUP
Read
The Cigna Group is a global health services organization providing a comprehensive suite of health insurance, pharmacy benefits management (PBM) through Express Scripts, and other health solutions. Its competitive moat is built on the integrated PBM and health plan model, leveraging significant scale, extensive provider networks, and data analytics to optimize care and manage costs. Cigna is a major player in the U.S. and international healthcare markets, offering holistic health and wellness programs.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 179.4B | 194.1B | 246.1B | 273.9B | 15.1% | 282.4B | 285.4B | 297.3B | 4.2% |
| EPS | 22.33 | 17.65 | 12.54 | 22.33 | 0.0% | 24.18 | 22.83 | 25.06 | 5.9% |
| Shares | 298.7M | 292.5M | 273.8M | 263.5M | -11.8% | 264.2M | — | — | — |
| Debt | 31.1B | 30.9B | 32.0B | 31.5B | 0.4% | 31.9B | — | — | — |
| Equity | 44.7B | 46.2B | 41.0B | 41.7B | -2.3% | — | — | — | — |
| Op CF | 8.7B | 11.8B | 10.4B | 9.6B | 3.5% | 10.3B | — | — | — |
| Inv CF | 3.1B | -5.2B | -2.1B | -4.4B | — | — | — | — | — |
| Fin CF | -11.2B | -4.3B | -7.6B | -6.4B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CI | The Cigna Group(you) | $73.7B | 92 | Strong Buy |
| ELV | Elevance Health, Inc. | $85.5B | 90 | Strong Buy |
| CVS | CVS Health Corporation | $119.0B | 93 | Strong Buy |
| HUM | Humana Inc. | $46.3B | 89 | Strong Buy |
| CNC | Centene Corporation | $32.0B | 93 | Strong Buy |
| UNH | UnitedHealth Group Incorporated | $352.7B | 90 | Strong Buy |
| OSCR | Oscar Health, Inc. | $9.4B | 98 | Strong Buy |
| SAUD3.SA | Bradsaúde S.A. | $7.9B | 98 | Strong Buy |
| MOH | Molina Healthcare, Inc. | $10.4B | 71 | Buy |
| PGNY | Progyny, Inc. | $2.0B | 98 | Strong Buy |
Peer medians: ROE 2.7% · P/E 23.6x · Gross margin 52.5%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.